Myriam Curet McAdams - 10 Feb 2026 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet
Issuer symbol
ISRG
Transactions as of
10 Feb 2026
Net transactions value
-$441,745
Form type
4
Filing time
11 Feb 2026, 17:37:49 UTC
Previous filing
30 Jan 2026
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curet Myriam EVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 11 Feb 2026 0001632901

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $0 +838 +205% $0.000000 1,247 10 Feb 2026 by Trust F1
transaction ISRG Common Stock Tax liability $205,514 -417 -33% $492.84 830 10 Feb 2026 by Trust F1
transaction ISRG Common Stock Options Exercise $24,086 +105 +13% $229.39 935 10 Feb 2026 by Trust F2
transaction ISRG Common Stock Sale $51,938 -105 -11% $494.65 830 10 Feb 2026 by Trust F2
transaction ISRG Common Stock Sale $208,378 -421 -51% $494.96 409 11 Feb 2026 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -105 -7.7% $0.000000 1,257 10 Feb 2026 Common Stock 105 $229.39 Direct F2, F3
transaction ISRG Restricted Stock Units Options Exercise $0 -838 -50% $0.000000 838 10 Feb 2026 Common Stock 838 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 RSUs vest 25% per year over a four year period, commencing on each anniversary of February 10, 2023. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F2 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F3 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F4 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.